Dr. Kenneth MacLeod is DMPK Technology Lead in the Drug Discovery Unit at the University of Dundee (DDU-UoD), UK. With extensive experience from 15 years in academia and contract research of developing novel in vitro, in vivo and bioanalytical approaches to tackle DMPK problems, Dr. MacLeod joined the DDU-UoD in 2020 to implement these methodologies in anti-infective drug discovery. Dr. MacLeod is currently involved with several academic / industrial collaborative programmes in Chagas disease, malaria, tuberculosis, schistosomiasis and cryptosporidiosis.
